ArticleLeukemia research reports2021

Use of gemtuzumab ozogamicin in relapsed refractory acute myeloid leukemia: Multi-center real life data from Turkey.

Ayşe Hilal Eroğlu Küçükdiler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.